Predictors of the unfavorable outcomes in acute ischemic stroke patients treated with alteplase, a multi-center randomized trial
Open Access
- 12 March 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Abstract
Worldwide, stroke is a leading cause of long-term disability in adults. Alteplase is the only approved treatment for acute ischemic stroke (AIS) and results in an improvement in a third of treated patients. We evaluated the post-stroke unfavourable outcome predictors in alteplase-treated patients from Egypt and Saudi Arabia. We assessed the effect of different risk factors on AIS outcomes after alteplase in Egypt and Saudi Arabia. Our study included 592 AIS alteplase-treated patients. The relationship between risk factors, clinical presentation, and imaging features was evaluated to predict factors associated with poor outcomes. An mRS score of three or more was used to define poor outcomes. Poor outcome was seen in 136 patients (23%), and Patients with unfavourable effects had significantly higher admission hyperglycaemia, a higher percentage of diabetes mellitus, cardioembolic stroke, and a lower percentage of small vessel stroke. Patients with higher baseline NIHSS score (OR 1.39; 95% CI 1.12–1.71; P = 0.003), admission hyperglycaemia (OR 13.12; 95% CI 3.37–51.1; P < 0.001), and post-alteplase intracerebral haemorrhage (OR 7.41; 95% CI 1.69–32.43; P = 0.008) independently predicted unfavourable outcomes at three months. In AIS patients treated with alteplase, similar to reports from other regions, in patients from Egypt and Saudi Arabia also reveal that higher NIHSS, higher serum blood sugar, and post-alteplase intracerebral haemorrhage were the predictors of unfavourable outcomes three months after ischemic stroke.Trial registration: (clinicaltrials.gov NCT06058884), retrospectively registered on 28/09/2023.Keywords
Funding Information
- Kafr El Shiekh University
This publication has 44 references indexed in Scilit:
- Association Between Thrombectomy and Functional Outcomes in Pediatric Patients With Acute Ischemic Stroke From Large Vessel OcclusionJAMA Neurology, 2023
- A randomized pilot study of the efficacy and safety of loading ticagrelor in acute ischemic strokeNeurological Sciences, 2022
- Association of white matter hyperintensities with migraine phenotypes and response to treatmentActa Neurologica Belgica, 2022
- Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic StrokeJAMA, 2019
- Predictors of Need for Critical Care Support, Adverse Events, and Outcome after Stroke ThrombolysisJournal of Stroke and Cerebrovascular Diseases, 2018
- Predictors of Outcome in Patients Presenting with Acute Ischemic Stroke and Mild Stroke Scale ScoresJournal of Stroke and Cerebrovascular Diseases, 2015
- Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsThe Lancet, 2014
- NIHSS-time score easily predicts outcomes in rt-PA patients: The SAMURAI rt-PA registryJournal of the Neurological Sciences, 2013
- Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational studyThe Lancet, 2007
- Global and regional burden of disease and risk factors, 2001: systematic analysis of population health dataThe Lancet, 2006